Meeder Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-442
| Closed | -$2.81K | – | 838 |
|
|
2024
Q2 | $2.81K | Hold |
442
| – | – | ﹤0.01% | 830 |
|
|
2024
Q1 | $2.68K | Hold |
442
| – | – | ﹤0.01% | 702 |
|
|
2023
Q4 | $2.68K | Hold |
442
| – | – | ﹤0.01% | 440 |
|
|
2023
Q3 | $1.87K | Hold |
442
| – | – | ﹤0.01% | 462 |
|
|
2023
Q2 | $1.37K | Hold |
442
| – | – | ﹤0.01% | 482 |
|
|
2023
Q1 | $614 | Hold |
442
| – | – | ﹤0.01% | 565 |
|
|
2022
Q4 | $880 | Hold |
442
| – | – | ﹤0.01% | 742 |
|
|
2022
Q3 | $1K | Sell |
442
-14,481
| -97% | -$32.8K | ﹤0.01% | 1911 |
|
|
2022
Q2 | $47K | Hold |
14,923
| – | – | ﹤0.01% | 881 |
|
|
2022
Q1 | $62K | Buy |
+14,923
| New | +$62K | ﹤0.01% | 907 |
|
|
2021
Q4 | – | Sell |
-16,775
| Closed | -$88K | – | 1179 |
|
|
2021
Q3 | $88K | Buy |
16,775
+273
| +2% | +$1.43K | ﹤0.01% | 933 |
|
|
2021
Q2 | $84K | Buy |
16,502
+14,685
| +808% | +$74.8K | ﹤0.01% | 951 |
|
|
2021
Q1 | $10K | Buy |
+1,817
| New | +$10K | ﹤0.01% | 1595 |
|
|
2020
Q4 | – | Sell |
-11,960
| Closed | -$47K | – | 1857 |
|
|
2020
Q3 | $47K | Sell |
11,960
-10,716
| -47% | -$42.1K | ﹤0.01% | 966 |
|
|
2020
Q2 | $109K | Buy |
22,676
+4,406
| +24% | +$21.2K | 0.01% | 743 |
|
|
2020
Q1 | $64K | Buy |
18,270
+4,268
| +30% | +$15K | 0.01% | 840 |
|
|
2019
Q4 | $67K | Sell |
14,002
-18,796
| -57% | -$89.9K | ﹤0.01% | 929 |
|
|
2019
Q3 | $94K | Buy |
32,798
+30,228
| +1,176% | +$86.6K | 0.01% | 824 |
|
|
2019
Q2 | $18K | Sell |
2,570
-9,094
| -78% | -$63.7K | ﹤0.01% | 1268 |
|
|
2019
Q1 | $166K | Buy |
11,664
+10,347
| +786% | +$147K | 0.01% | 580 |
|
|
2018
Q4 | $18K | Sell |
1,317
-10,093
| -88% | -$138K | ﹤0.01% | 1084 |
|
|
2018
Q3 | $253K | Buy |
11,410
+10,259
| +891% | +$227K | 0.02% | 471 |
|
|
2018
Q2 | $18.9K | Buy |
+1,151
| New | +$18.9K | ﹤0.01% | 976 |
|